BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a Chief Investment Officer. This is a routine update to the company's management structure.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
Gland Pharma Ltd
Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026
Gland Pharma Ltd has appointed Mr. Xiao Le as the Chief Investment Officer of its wholly-owned subsidiary Gland Pharma International Pte. Ltd, effective November 09, 2026. Mr. Xiao Le has over 15 years of experience in investment and assets management in the medical devices, biopharma, Dx/Tools, and healthcare services sectors.
BSECompany Update▼ NegativeResults2d ago
Silverline Technologies Ltd
Announcement under Regulation 30 (LODR)- Newspaper Publication
Silverline Technologies Ltd announces unaudited financial results for the quarter ended September 30, 2026, with net profit/loss for the period before tax at Rs. (49.83) lakhs, compared to Rs. (17.49) lakhs in the same quarter last year.
NSEAppointmentMgmt Change2d ago
Gland Pharma Limited
Appointment
Gland Pharma Limited has appointed Mr. Xiao Le as the Chief Investment Officer for its wholly-owned subsidiary, Gland Pharma International Pte. Ltd., effective November 09, 2026. Mr. Xiao Le will be responsible for exploring investment opportunities and improving M&A capability for Gland in the US, China, Singapore, and other countries.
NSEPress Release▲ PositiveResults3d ago
Shyam Metalics and Energy Limited
Press Release
Shyam Metalics and Energy Limited has reaffirmed its credit ratings from CRISIL, with a long-term rating of 'CRISIL AA+/Stable' and a short-term rating of 'CRISIL A1+'. The company's bank debt rating has been enhanced to ₹4,500 Crore, and its ₹50 Crore Commercial Paper programme has been reaffirmed at 'CRISIL A1+'.